Open original FDA record ↗Recall record
- FDA identifier
- Z-0660-2019
- Company in FDA record
- Randox Laboratories Ltd.
- FDA record creation date
- Dec 21, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Calibrator value sheets have been modified for assigned value of Alpha-1-Acid-Glycoprotein (AGP), IgA and IgG to improve the alignment. IgG measurement reference has also been corrected.
Source facts
- Action
- On November 19, 2018, Randox Laboratories Ltd. issued "Urgent Medical Device Correction" notices and New Calibrator Value sheets (Revised 15 Nov 18 pl) to customers. Customers were advised to take the following action: - Review all remaining stock. Add the notice and replace the calibrator value sheet with the revised document provided. - Discuss the contents of the notice with your Medical Director. Review results generated with the affected batches in line with the clinical profile of the patient. - Retain a copy of the letter with laboratory records and forward a copy of the letter to those who may have received this product. - Return the completed response form via email to technical.services@randox.com. If you have any questions, contact RA Specialist by email at maria.kelly@randox.com.
- Initiated
- 2018-11-19
- Root cause
- Under Investigation by firm
- Terminated
- 2020-04-23
- Distribution
- US Distribution to states of : IN, NJ, NY, TX and WV and internationally to Ireland.
- Recall number
- Z-0660-2019
- Recall status
- Terminated
- CDRH record ID
- 169364
- FDA record created
- 2018-12-21
- Recall event number
- 81664